Clinical trialNCT02369406Active, not recruitingPhase 2/PHASE3Interventional

Early Infant HIV Treatment in Botswana

SponsorHarvard School of Public Health (HSPH)Enrollment67HIVPediatric AIDS

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The overall objective of this study is to determine whether very early antiretroviral treatment (ART) initiation in HIV-infected infants limits the seeding of viral reservoirs and maintains immune responses, potentially allowing future periods off ART.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel R. Kuritzkes, MD
Brigham and Women's Hospital
Principal Investigator
clinicaltrials.gov ↗
Mathias Lichterfeld, MD, PhD
Ragon Institute of MGH, MIT and Harvard
Principal Investigator
clinicaltrials.gov ↗
Roger L Shapiro, MD, MPH
Harvard School of Public Health (HSPH)
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Botswana

Botswana Harvard Hiv/aids Institute Partnership
Gaborone, Botswana

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

KaletraLamivudine →Nevirapine →Zidovudine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 May 2015
Primary completion: 6 Nov 2020
Completion: 30 Jun 2029
Last update posted: 23 Feb 2026
Registered enrollment: 67
Registry id: NCT02369406

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.